Sign in
Taking peopleNo phase

Russian Extreme Hypertriglyceridemia Registry

Key facts

Who runs it
Russian Cardiology Research and Production Center
Where
Russia6 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
500 people, planned
Started
20 Nov 2025
Expected to end
Dec 2045
Type of study
Observational
Record updated
2 April 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L), confirmed by at least two independent measurements
  • Written informed consent from the patient or legal guardian
  • No age restrictions

Who cannot take part

  • Patients whose extreme hypertriglyceridemia is caused by alcohol abuse, uncontrolled diabetes, or other medical conditions, unless extreme hypertriglyceridemia is confirmed after controlling the underlying condition
  • Lack of informed consent

This trial is currently available in Russia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.

The group in the trial

  • Extreme Hypertriglyceridemia

    Patients with triglyceride levels ≥10 mmol/L, confirmed by at least two independent measurements, under the care of participating lipid centers in the Russian Federation.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Russian Extreme Hypertriglyceridemia Registry (REGGI)
Record updated
2 April 2026